Business Context and Reporting Period
This Form 8-K is filed by General Enterprise Ventures, Inc. (not Citrotech Inc.) with a report date of October 15, 2025. The filing discloses a material definitive agreement entered into on October 21, 2025, regarding a Private Investment in Public Equity (PIPE) offering, and the appointment of two new directors effective October 15, 2025.
Key Financial Metrics and Transaction Details
The filing details a capital raise transaction rather than standard operating financial results. Key metrics include:
- Gross Proceeds: $2,909,515 from the sale of 193,967 shares of Series C Convertible Preferred Stock.
- Offering Price: $15.00 per share of Series C Preferred Stock.
- Conversion Terms: Each Preferred share converts into 3.3333 shares of Common Stock.
- Warrants Issued: Warrants to purchase up to 323,276 shares of Common Stock at an exercise price of $6.00 per share, expiring in five years.
- Placement Agent Fees: 8% cash fee of gross proceeds plus warrants equal to 5% of total Common Stock issuable upon conversion and exercise.
- Liquidity: No trading market exists for the Preferred Stock or PIPE Warrants; the Company does not intend to list them on any exchange.
Note: The filing text does not provide clear values for revenue, profit, cash flow, margins, or existing debt levels.
Material Changes and Corporate Actions
The primary material changes reported are:
- Capital Structure: Issuance of unregistered equity securities (Series C Preferred Stock and warrants) to accredited investors under Section 4(a)(2) of the Securities Act.
- Board Composition: Appointment of Lorenzo Calinawan and Craig Huff to the Board of Directors.
- Ownership: Craig Huff is identified as a significant shareholder via BoltRock Holdings LLC.
Outlook, Risks, and Management Commentary
Management Commentary: The Company highlights the extensive experience of the new directors, including Mr. Huff's background in opportunistic investment and nuclear engineering, and Mr. Calinawan's expertise in M&A within the chemicals and industrial sectors.
Risks and Contingencies:
- Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ materially from projections due to known and unknown risks.
- Liquidity Risk: The newly issued securities are not registered and have no public trading market.
- Regulatory Risk: Securities were sold only to accredited investors under an exemption from registration.
Investor Verification Checklist
- Verify the exact number of Common Stock shares issuable upon full conversion of the Series C Preferred Stock and exercise of all warrants.
- Confirm the dilution impact on existing shareholders given the 3.3333 conversion ratio and warrant coverage.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants and redemption rights.
- Assess the Company's current cash position and burn rate to determine how long the $2.9 million in proceeds will sustain operations.
- Check for any subsequent filings regarding the listing status of the Common Stock or the Preferred Stock.